foxo4-dri senolytic peptide 2023

foxo4-dri senolytic peptide 2023 mouse study 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Targeted Apoptosis of Senescent Cells

Name: foxo4-dri senolytic peptide 2023 mouse study 2024 Molecular modelling of the FOXO4-TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4-DRI Targeted Apoptosis of Senescent Cells
Brand: equiscorp.hu
SKU: 6993081624
Price: 29.64 USD
Availability: InStock
Rating: 4.2052000000000005 (8 reviews)

Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging PMC FOXO4 DRI: The Senolytic Peptide That Targets Zombie Cells and Aging Revolution Health & Wellness FOXO4 DRI Peptide Dosing Guide: Senolytic Peptide Protocol (June 2026) Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv

SKU: 6993081624 · From equiscorp.hu

4.2

USD29.64 USD69.64

Pay in 4 interest-free payments of $7.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Description

Dihexa works by binding to the HGF receptor c-Met on hippocampal neurons, activating intracellular signaling pathways that increase synaptogenesis, dendritic spine density, and NMDA receptor expression